Neoadjuvant, perioperative, or adjuvant immunotherapy in resectable non-small cell lung cancer: How do I choose? Importance of immune biomarkers and molecular testing
1 Thoracic Oncology Program, Division of Thoracic Surgery, University of California, Los Angeles, Los Angeles, Calif. Electronic address: jaymoonlee@mednet.ucla.edu.